IGHE and neoplasm: Although at a lower concentration than the other subclasses, IgE was also significantly increased within the tumor (Figure 1L), confirming data from a small cohort of human PDAC patients, where patient-derived IgE was found upregulated and exerted antitumoral activity via ADCC (33).